SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

06 Aug 2024 Evaluate
The June 2024 quarter revenue stood at Rs. 122.90 millions, up 6.46% as compared to Rs. 115.44 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2024 is Rs. -12.20 millions as compared to Net Loss of Rs. -24.60 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 improved to -1.32% as compared to -15.96% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 122.90 115.44 6.46 122.90 115.44 6.46 490.89 425.47 15.38
Other Income 1.38 1.90 -27.37 1.38 1.90 -27.37 11.52 11.37 1.32
PBIDT -1.32 -15.96 -91.73 -1.32 -15.96 -91.73 -26.09 -29.97 -12.95
Interest 3.89 3.48 11.78 3.89 3.48 11.78 16.34 13.81 18.32
PBDT -5.21 -19.44 -73.20 -5.21 -19.44 -73.20 -42.43 -43.78 -3.08
Depreciation 7.15 6.69 6.88 7.15 6.69 6.88 27.15 23.99 13.17
PBT -12.36 -26.13 -52.70 -12.36 -26.13 -52.70 -69.58 -67.77 2.67
TAX -0.16 -1.53 -89.54 -0.16 -1.53 -89.54 -0.06 -4.15 -98.55
Deferred Tax -0.16 -1.53 -89.54 -0.16 -1.53 -89.54 -0.04 -4.30 -99.07
PAT -12.20 -24.60 -50.41 -12.20 -24.60 -50.41 -69.52 -63.62 9.27
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) -1.07 -13.83 -92.23 -1.07 -13.83 -92.23 -5.31 -7.04 -24.55

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×